We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
dc.contributor.author | Odendaal, M.W.![]() |
|
dc.contributor.author | Morris, S.![]() |
|
dc.contributor.author | Du Preez, E.![]() |
|
dc.contributor.author | Aitchison, Henry![]() |
|
dc.contributor.editor | Verwoerd, Daniel Wynand | |
dc.date.accessioned | 2012-12-12T08:50:56Z | |
dc.date.available | 2012-12-12T08:50:56Z | |
dc.date.created | 2012 | |
dc.date.issued | 1997 | |
dc.description | The articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat X Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format. | en_US |
dc.description.abstract | A multivalent vaccine consisting of inactivated bovine herpes virus-1 (BHV-1 ). also known as infectious bovine rhinotracheitis virus (IBR) , para-influenza type-3 virus (PIȝ) and the leukotoxin of Pasteurella haemolytica A 1, were combined with the addition of aluminium hydroxide as adjuvant, and administered to post-weaned calves, and the serum tested for seroconversion to each antigen. Two groups of calves (n = 150 and n = 68) were used and were randomly divided into three subgroups. The first group of 150 calves were immunized with the multivalent vaccine (three batches) to test its first-stage stability (vaccine 3 months old) and the second group were immunized with the same vaccine 1 year later, in order to test its immunogenicity. A significant increase in titres occurred after the day 0 and 28 immunizations, for each of the three antigens in the multivalent vaccine, as measured on days 0 and 42. lmmunoconversion occurred after immunization with the 3-month- and 1-year-old vaccine. The immunogenic stability of antigens in the vaccine was demonstrated after a 1-year period when the vaccine was kept at 4-6 °C. | en_US |
dc.identifier.citation | Odendaal, MW, Morris, S, Du Preez, E & Aitchison, H 1997, 'The humoral immune response in cattle after immunization with a multivalent IBR/PI 3/ Pasteurella haemolytica A1 leukotoxin vaccine’. Onderstepoort Journal of Veterinary Research, vol. 64, no. 3, pp. 205-212. | en_US |
dc.identifier.issn | 0330-2465 | |
dc.identifier.uri | http://hdl.handle.net/2263/20746 | |
dc.language.iso | en | en_US |
dc.publisher | Published by the Agricultural Research Council, Onderstepoort Veterinary Institute | en_US |
dc.rights | © ARC-Onderstepoort (original). © University of Pretoria. Dept of Library Services (digital). | en_US |
dc.subject | Veterinary medicine | en_US |
dc.subject | BHV-1 | en_US |
dc.subject | Bovine herpes virus-1 | en_US |
dc.subject | Cattle | en_US |
dc.subject | IBR | en_US |
dc.subject | Immunoconversion | en_US |
dc.subject | Immunogenicity | en_US |
dc.subject | Infectious bovine tracheitis | en_US |
dc.subject | Multivalent vaccine | en_US |
dc.subject | Para-influenza | en_US |
dc.subject | Pasteurella haemolytica | en_US |
dc.subject | PIȝ | en_US |
dc.subject.lcsh | Veterinary medicine -- South Africa | |
dc.title | The humoral immune response in cattle after immunization with a multivalent IBR/PI 3/ Pasteurella haemolytica A1 leukotoxin vaccine | en_US |
dc.type | Article | en_US |